A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

Clinical trial NCT00462761 · COMPLETED

Trial details

NCT number: NCT00462761
Sponsor: Daiichi Sankyo
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Leukemia Myelodysplastic Syndrome AML MDS

Start date: 2007-01-01
Primary completion: 2009-03-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.